Several GLS inhibitors have been developed, among which CB-839 is currently undergoing clinical trials as a potent, orally bioavailable GLS-selective inhibitor for the treatment of various cancers, including TNBC, NSCLC, and colon cancer (NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600)
Performance Applications: Muscle Hypertrophy: Lean mass development, strength enhancement Body Composition: Fat reduction, improved muscle-to-fat ratio Recovery Acceleration: Reduced downtime between training sessions Sleep Optimization: Enhanced deep sleep for better recovery Anti-Aging Benefits: Improved vitality, skin quality, cognitive function Metabolic Enhancement: Better insulin sensitivity, energy utilization Physiological Action: Sermorelin functions as a growth hormone-releasing hormone (GHRH) analog, binding to specific receptors in the anterior pituitary gland
Cardiolipin may also contribute to the formation of neutrophil extracellular traps
Research involving animals suggests that specific bacterial species, such as Akkermansia muciniphila ( A